154 related articles for article (PubMed ID: 1939253)
1. Protease specificity and heparin binding and activation of recombinant protease nexin I.
Evans DL; McGrogan M; Scott RW; Carrell RW
J Biol Chem; 1991 Nov; 266(33):22307-12. PubMed ID: 1939253
[TBL] [Abstract][Full Text] [Related]
2. Protease nexin. Properties and a modified purification procedure.
Scott RW; Bergman BL; Bajpai A; Hersh RT; Rodriguez H; Jones BN; Barreda C; Watts S; Baker JB
J Biol Chem; 1985 Jun; 260(11):7029-34. PubMed ID: 3997857
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
Stone SR; Le Bonniec BF
J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
[TBL] [Abstract][Full Text] [Related]
4. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
Myles T; Church FC; Whinna HC; Monard D; Stone SR
J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanism of serpins. Interaction of thrombin with antithrombin and protease nexin 1.
Stone SR; Hermans JM
Biochemistry; 1995 Apr; 34(15):5164-72. PubMed ID: 7711036
[TBL] [Abstract][Full Text] [Related]
6. Effect of heparin on the glia-derived-nexin-thrombin interaction.
Wallace A; Rovelli G; Hofsteenge J; Stone SR
Biochem J; 1989 Jan; 257(1):191-6. PubMed ID: 2920011
[TBL] [Abstract][Full Text] [Related]
7. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
8. Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin.
Izaguirre G; Zhang W; Swanson R; Bedsted T; Olson ST
J Biol Chem; 2003 Dec; 278(51):51433-40. PubMed ID: 14532267
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the heparin-binding site of glia-derived nexin/protease nexin-1.
Rovelli G; Stone SR; Guidolin A; Sommer J; Monard D
Biochemistry; 1992 Apr; 31(13):3542-9. PubMed ID: 1554734
[TBL] [Abstract][Full Text] [Related]
10. Localization of the heparin-binding site of glia-derived nexin/protease nexin-1 by site-directed mutagenesis.
Stone SR; Brown-Luedi ML; Rovelli G; Guidolin A; McGlynn E; Monard D
Biochemistry; 1994 Jun; 33(24):7731-5. PubMed ID: 8011637
[TBL] [Abstract][Full Text] [Related]
11. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.
Chuang YJ; Swanson R; Raja SM; Olson ST
J Biol Chem; 2001 May; 276(18):14961-71. PubMed ID: 11278930
[TBL] [Abstract][Full Text] [Related]
12. Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein.
Kasza A; Petersen HH; Heegaard CW; Oka K; Christensen A; Dubin A; Chan L; Andreasen PA
Eur J Biochem; 1997 Sep; 248(2):270-81. PubMed ID: 9346278
[TBL] [Abstract][Full Text] [Related]
13. The efficient catabolism of thrombin-protease nexin 1 complexes is a synergistic mechanism that requires both the LDL receptor-related protein and cell surface heparins.
Knauer MF; Kridel SJ; Hawley SB; Knauer DJ
J Biol Chem; 1997 Nov; 272(46):29039-45. PubMed ID: 9360977
[TBL] [Abstract][Full Text] [Related]
14. Protease nexin-2/amyloid beta-protein precursor inhibits factor Xa in the prothrombinase complex.
Mahdi F; Van Nostrand WE; Schmaier AH
J Biol Chem; 1995 Oct; 270(40):23468-74. PubMed ID: 7559509
[TBL] [Abstract][Full Text] [Related]
15. Binding of protease nexin-1 to the fibroblast surface alters its target proteinase specificity.
Wagner SL; Lau AL; Cunningham DD
J Biol Chem; 1989 Jan; 264(1):611-5. PubMed ID: 2642483
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site.
Theunissen HJ; Dijkema R; Grootenhuis PD; Swinkels JC; de Poorter TL; Carati P; Visser A
J Biol Chem; 1993 Apr; 268(12):9035-40. PubMed ID: 8473344
[TBL] [Abstract][Full Text] [Related]
17. Interaction of activated protein C with serpins.
Hermans JM; Stone SR
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):239-45. PubMed ID: 8216224
[TBL] [Abstract][Full Text] [Related]
18. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
Huntington JA; Gettins PG
Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
[TBL] [Abstract][Full Text] [Related]
19. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
[TBL] [Abstract][Full Text] [Related]
20. Identification of thrombin residues that modulate its interactions with antithrombin III and alpha 1-antitrypsin.
Le Bonniec BF; Guinto ER; Stone SR
Biochemistry; 1995 Sep; 34(38):12241-8. PubMed ID: 7547966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
